Shares of Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) reached a new 52-week high during trading on Friday . The stock traded as high as C$13.49 and last traded at C$13.49, with a volume of 202 shares changing hands. The stock had previously closed at C$13.27. Analysts Set New Price Targets A number of equities research analysts have issued reports on FRX shares. Cantor Fitzgerald raised shares of Fennec Pharmaceuticals from a 'neutral' rating to an 'overweight' rating in a report on Tuesday, November 22nd.

https://www.dailypolitical.com/2022/12/09/fennec-pharmaceuticals-tsefrx-hits-new-1-year-high-at-13-49.html

#dailypolitical